Becky Riggs | Neuroimaging | Best Researcher Award

Published on by Neuroscientists

Dr. Becky Riggs | Neuroimaging | Best Researcher Award

Dr. Becky Riggs |  OHSU Doernbecher Children’s Hospital | United States

Dr. Rebecca J. Riggs is an accomplished physician–scientist and academic leader in pediatric critical care and neurocritical care. With advanced training in pediatrics, critical care, and neurocritical care at top U.S. institutions, she has built a career that blends clinical excellence, research innovation, and educational leadership. Her research centers on ultrasound medicine, neuro-monitoring, viral pathogens affecting the nervous system, and neurodevelopmental outcomes of critically ill children. She has served as principal investigator in national multi-center studies funded by the NIH and CDC, contributing to evidence-based guidelines for conditions such as acute flaccid myelitis and pediatric COVID-19. Alongside her research, she has directed neurocritical care programs, led safety and quality initiatives, and mentored future physicians. Her work demonstrates a rare combination of technical expertise, collaborative leadership, and a commitment to advancing both patient care and the broader field of pediatric intensive care medicine.

Profile

Scopus

Early Academic Pursuits

Rebecca J. Riggs, widely known as Becky, laid the foundation for her medical career through an early commitment to both emergency medicine and the social sciences. With training as an emergency medical technician and paramedic, followed by a degree in women’s studies, she cultivated a broad perspective that combined scientific rigor with a deep awareness of social contexts. This unique academic blend informed her later clinical approach, emphasizing both medical expertise and patient-centered care. She advanced her education by completing her medical degree at the University of Tennessee College of Medicine, and subsequently pursued specialized training in pediatrics, pediatric critical care, and pediatric neurocritical care at leading institutions across the United States.

Professional Endeavors

Dr. Riggs’ professional path reflects her dedication to pediatric intensive care and academic medicine. She held early faculty roles at Johns Hopkins University School of Medicine, where she became a key figure in pediatric anesthesiology and critical care medicine. Her work extended beyond bedside care into administrative leadership, including directing pediatric neurocritical care services and serving on multiple institutional committees aimed at advancing patient safety, quality improvement, and team culture within the intensive care environment. Later, her transition to Oregon Health & Science University marked a continuation of her leadership in pediatric critical care, where she now serves as an associate professor and directs programs that integrate neurology, cardiology, and intensive care.

Contributions to Neurocritical Care

Central to Dr. Riggs’ career has been her pioneering contributions to the development and expansion of pediatric neurocritical care. She co-directed and later directed programs that established protocols, pathways, and education models for the care of critically ill children with neurological conditions. Her leadership in culture change initiatives within the pediatric intensive care unit highlights her commitment to improving team dynamics and patient-centered outcomes. She has also served as a mentor and educator, leading simulations, workshops, and educational events to strengthen the capacity of clinicians in this demanding subspecialty.

Research Focus

Dr. Riggs’ scholarly contributions are strongly anchored in her research on ultrasound medicine and neuro-monitoring in critically ill children. Her investigations include ophthalmic ultrasonography, neurosonography, and contrast-enhanced ultrasonography, all aimed at enhancing diagnostic accuracy and monitoring in neonatal and pediatric intensive care settings. She has been particularly engaged in studying viral pathogens with neurological effects and in examining the neurodevelopmental outcomes of children after critical illness. Her role as site principal investigator for multi-center studies funded by the NIH and CDC underscores her central position in national efforts to improve understanding and care of acute flaccid myelitis and pediatric COVID-19 outcomes.

Leadership in Collaborative Studies

Dr. Riggs has played a vital role in large-scale, collaborative pediatric studies of national importance. She served as the Johns Hopkins site principal investigator for the NIH-funded Acute Flaccid Myelitis Natural History study, contributing to the creation of evidence-based guidelines for this rare but devastating condition. She also guided institutional involvement in the CDC-funded Overcoming COVID-19 study, which shaped the understanding of how children are affected by emerging viral illnesses. Through these collaborations, she has demonstrated an ability to bridge clinical expertise with research that informs global health policy and clinical standards.

Accolades and Recognition

Her research achievements have been supported by competitive federal funding, including NIH Loan Repayment Program awards for her pioneering work in pediatric ophthalmic ultrasound and imaging in cases of traumatic brain injury. These grants reflect recognition of both the novelty and impact of her research directions. Her leadership appointments at Johns Hopkins and Oregon Health & Science University further testify to her peers’ trust in her capacity to shape the future of pediatric critical care medicine.

Impact, Influence, and Future Contributions

The impact of Dr. Riggs’ work is evident in the improved protocols, expanded research pathways, and enhanced patient care strategies she has championed. By integrating ultrasound technology into pediatric neurocritical care, she has opened new avenues for bedside diagnostics and monitoring. Her influence extends through her leadership in guideline development, her mentorship of future physicians, and her advocacy for collaborative approaches to rare and emerging pediatric conditions. Looking ahead, her ongoing research and clinical leadership are poised to further shape the evolving field of pediatric neurocritical care, leaving a legacy of innovation, compassion, and transformative impact on children’s health worldwide.

Publications

1. Ophthalmic ultrasonography can identify retinal injury associated with abusive head trauma more quickly and accurately than other neuroimaging modalities — Authors: (not listed), 2025

2. A novel approach to thrombectomy and catheter directed tissue-type plasminogen activator in a toddler post-fontan — Authors: (not listed), 2024

Conclusion

Dr. Riggs’ career reflects a profound dedication to improving the lives of critically ill children through innovation in research, excellence in clinical care, and leadership in program development. Her contributions have significantly advanced pediatric neurocritical care by integrating novel diagnostic tools, shaping national guidelines, and fostering collaborative research networks. With her continued focus on emerging pathogens and neurodevelopmental outcomes, she is poised to further influence the future of pediatric intensive care on both national and international levels. Her legacy will be defined by her impact on patient outcomes, her mentorship of future leaders, and her role in shaping the evolving landscape of pediatric neurocritical care.

 

İlyas UÇAR | Neuroimaging | Trailblazer in Neuroscience Award

Published on by Neuroscientists

Assoc.Prof.Dr. Ilyas UÇAR | Neuroimaging | Trailblazer in Neuroscience Award

Assoc. Prof. Dr. Ilyas UÇAR,  Erciyes University, Turkey.

İlyas Uçar is a dedicated academic and researcher specializing in anatomical sciences, particularly in developmental anatomy and teratology. His academic journey began with a Bachelor’s degree in Physiotherapy and Rehabilitation, followed by a Master’s and Ph.D. in Anatomy (Medicine) from Erciyes University. His research has focused on the effects of pharmaceutical agents such as Interferon and Paracetamol on embryonic and fetal development, shedding light on critical concerns regarding drug safety during pregnancy. As an Associate Professor, he has contributed to academia through teaching, mentorship, and interdisciplinary research, earning recognition for his impactful work. His studies have influenced medical guidelines and inspired  further research into prenatal health.

Profile

Google Scholar

Orcid

📚 Early Academic Pursuits

İlyas Uçar embarked on his academic journey with a deep-rooted interest in health sciences, particularly in the intricate mechanisms of human anatomy. He earned his Bachelor’s degree in Physiotherapy and Rehabilitation from Abant İzzet Baysal University in 2007, where he developed a strong foundation in musculoskeletal function and rehabilitation techniques. His passion for understanding the human body at a deeper level led him to pursue postgraduate studies, marking the beginning of an extensive academic exploration.

His pursuit of higher education continued at Erciyes University, where he completed his Master’s degree in Anatomy (Medicine) in 2014. Under the guidance of Doç. Dr. Tolga Ertekin, he conducted groundbreaking research on the effects of Interferon beta-1a (IFNβ-1A) and Interferon beta-1b (IFNβ-1B) on in vitro embryonic development. This study not only refined his expertise in developmental anatomy but also set the stage for his future contributions to teratology and embryological research.

🏥 Professional Endeavors

With a strong academic foundation, İlyas Uçar transitioned into professional academia, where he merged his passion for teaching with his commitment to scientific discovery. His doctoral studies at Erciyes University’s Institute of Health Sciences were a significant milestone, culminating in his Ph.D. in Anatomy (Medicine) in 2018. His dissertation, supervised by Prof. Dr. Erdoğan Unur, explored the potential teratogenic effects of paracetamol on fetal bone development, shedding light on critical concerns regarding prenatal medication exposure.

Following his doctoral achievements, he took on an active role in academia, mentoring students and engaging in interdisciplinary research. His teaching methods, rooted in both theoretical knowledge and practical application, have made a lasting impact on students specializing in anatomy and health sciences.

🔬 Contributions and Research Focus

İlyas Uçar’s research focuses on developmental anatomy, particularly the impact of pharmaceutical agents on embryonic and fetal growth. His studies on interferons and paracetamol have contributed valuable insights into the possible risks associated with commonly used medications during pregnancy. Through meticulous experimental methodologies, he has explored the implications of these substances on skeletal formation, paving the way for further advancements in medical safety guidelines.

In addition to his work in teratology, he has delved into the broader aspects of anatomical sciences, bridging the gap between clinical applications and fundamental research. His interdisciplinary approach has fostered collaborations with medical professionals, physiologists, and pharmacologists, further enriching the field of health sciences.

🏅 Accolades and Recognition

Throughout his career, İlyas Uçar has earned recognition for his dedication to research and education. His scholarly contributions have been acknowledged in scientific circles, with his research findings being cited in academic discussions on embryology and anatomy. His work has not only contributed to medical literature but has also influenced guidelines on drug safety during pregnancy.

As an esteemed faculty member, he has played a pivotal role in shaping the academic curriculum, ensuring that students receive a well-rounded education in anatomical sciences. His ability to inspire and guide young researchers has cemented his reputation as a mentor and leader in his field.

🌍 Impact and Influence

The influence of İlyas Uçar extends beyond the lecture halls and research laboratories. His findings have raised awareness about the importance of cautious pharmaceutical use during pregnancy, prompting further investigations into the long-term effects of medications on fetal development. His work continues to serve as a reference point for medical researchers, policymakers, and healthcare professionals seeking to enhance patient safety.His collaborations with medical institutions and research centers have facilitated knowledge exchange, ensuring that his discoveries have practical implications in clinical and pharmacological settings. By addressing critical questions in developmental anatomy, he has contributed to the broader understanding of how external factors influence human growth and development.

Publication

  • Effect of respiratory muscle training on pulmonary function and aerobic endurance in soccer players
    T. Ozmen, G.Y. Gunes, I. Ucar, H. Dogan, T.U. Gafuroglu – 2017

 

  • The effect of kinesio taping versus stretching techniques on muscle soreness, and flexibility during recovery from Nordic hamstring exercise
    T. Ozmen, G.Y. Gunes, H. Dogan, I. Ucar, M. Willems – 2017

 

  • The relationship between muscle size, obesity, body fat ratio, pain, and disability in individuals with and without nonspecific low back pain
    I. Ucar, C. Kararti, I. Cüce, E. Veziroğlu, A. Özüdoğru, F.A. Koçak, Y. Dadalı – 2021

 

  • Is scoliosis related to mastication muscle asymmetry and temporomandibular disorders? A cross-sectional study
    I. Ucar, S. Batin, M. Arik, A. Payas, E. Kurtoğlu, C. Kararti, T. Seber, et al. – 2022

 

  • Is the integration problem in the sensorimotor system the cause of adolescent idiopathic scoliosis?
    A. Payas, S. Batin, E. Kurtoğlu, M. Arik, T. Seber, I. Ucar, E. Unur – 2023

 

  • Analysis of changes in brain morphological structure of Taekwondo athletes by diffusion tensor imaging
    E. Kurtoğlu, A. Payas, S. Düz, M. Arik, I. Ucar, T.T. Tokmak, M.F. Erbay, N. Acer, et al. – 2023

 

  • The role of pineal gland volume in the development of scoliosis
    S. Batin, Y. Ekinci, K. Gürbüz, A. Payas, E. Kurtoğlu, I. Ucar, T. Seber, M. Arik, et al. – 2023

 

  • Masseter muscle thickness and elasticity in bruxism after exercise treatment: A comparison trial
    I. Ucar, C. Kararti, Y. Dadali, A. Özüdoğru, M. Okçu – 2022

 

  • The potential teratogenic effects of interferon beta-1a and interferon beta-1b on in vitro embryonic development
    I. Ucar, T. Ertekin, M. Nisari, D. Ceylan, Ö. Al, H. Ülger – 2016

 

  • Morphometric evaluation of acetabulum
    G.B. Uzun, M. Değermenci, I. Ucar, A. Arslan, M. Nisari – 2020

🔍 Conclusion

İlyas Uçar’s contributions to anatomical sciences extend beyond theoretical research, making a tangible impact on medical education and drug safety. His investigations into embryonic development have deepened the understanding of teratogenic risks, guiding both researchers and healthcare professionals. With a commitment to advancing knowledge through interdisciplinary collaboration, he continues to shape the future of anatomical and medical research. His legacy lies not only in his scientific discoveries but also in his role as an educator and mentor, ensuring that future generations carry forward his passion for medical science.